Phase I Trial of Venetoclax in Combination With R-ICE (V+RICE) Chemotherapy for Relapsed/Refractory Diffuse Large B-cell Lymphoma
Phase of Trial: Phase I
Latest Information Update: 28 Aug 2017
At a glance
- Drugs Venetoclax (Primary) ; Carboplatin; Etoposide; Ifosfamide; Rituximab
- Indications Diffuse large B cell lymphoma
- Focus Adverse reactions
- 18 Aug 2017 Status changed from not yet recruiting to recruiting.
- 25 Apr 2017 Planned End Date changed from 15 Aug 2019 to 15 Mar 2020.
- 25 Apr 2017 Planned primary completion date changed from 15 Apr 2018 to 15 Nov 2018.